Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease
ConclusionPatients with steroid-refractory GI aGVHD had higher fecal calprotectin levels and lower albumin levels than patients with steroid-responsive disease. We recommend further studies to evaluate non-invasive tests with fecal calprotectin in combination with albumin in predicting steroid refractory disease at onset of symptoms to potentially identify patients that may benefit from upfront escalation in GVHD treatment.
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Gastroenterology | Hematology | Inflammatory Bowel Disease | Pediatrics | Stem Cell Therapy | Stem Cells | Study | Transplants